India · Delayed Price · Currency is INR Theseus Pharmaceuticals Statistics
Total Valuation
BOM:542651 has a market cap or net worth of INR 328.76 billion. The enterprise value is 316.49 billion.
| Market Cap | 328.76B |
| Enterprise Value | 316.49B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
| Current Share Class | 271.93M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 162.91M |
Valuation Ratios
The trailing PE ratio is 40.72 and the forward PE ratio is 37.47.
| PE Ratio | 40.72 |
| Forward PE | 37.47 |
| PS Ratio | 5.46 |
| PB Ratio | 11.29 |
| P/TBV Ratio | 21.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 39.20 |
| EV / Sales | 5.26 |
| EV / EBITDA | 26.60 |
| EV / EBIT | 30.77 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | n/a |
| Interest Coverage | 24.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.40% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.67M |
| Profits Per Employee | 627,157 |
| Employee Count | 12,873 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:542651 has paid 2.84 billion in taxes.
| Income Tax | 2.84B |
| Effective Tax Rate | 26.04% |
Stock Price Statistics
The stock price has decreased by -33.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -33.67% |
| 50-Day Moving Average | 1,296.00 |
| 200-Day Moving Average | 1,341.28 |
| Relative Strength Index (RSI) | 40.86 |
| Average Volume (20 Days) | 53,101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542651 had revenue of INR 60.16 billion and earned 8.07 billion in profits. Earnings per share was 29.51.
| Revenue | 60.16B |
| Gross Profit | 20.81B |
| Operating Income | 10.30B |
| Pretax Income | 10.92B |
| Net Income | 8.07B |
| EBITDA | 11.09B |
| EBIT | 10.30B |
| Earnings Per Share (EPS) | 29.51 |
Balance Sheet
The company has 15.72 billion in cash and 3.45 billion in debt, giving a net cash position of 12.27 billion.
| Cash & Cash Equivalents | 15.72B |
| Total Debt | 3.45B |
| Net Cash | 12.27B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 29.12B |
| Book Value Per Share | 107.37 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 34.59%, with operating and profit margins of 17.12% and 13.42%.
| Gross Margin | 34.59% |
| Operating Margin | 17.12% |
| Pretax Margin | 18.14% |
| Profit Margin | 13.42% |
| EBITDA Margin | 18.43% |
| EBIT Margin | 17.12% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 8.50, which amounts to a dividend yield of 0.70%.
| Dividend Per Share | 8.50 |
| Dividend Yield | 0.70% |
| Dividend Growth (YoY) | 26.87% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | 0.56% |
| Earnings Yield | 2.46% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |